Genomma Lab Internacional
Genomma Lab Internacional, a leading player in the pharmaceutical and personal care industry, is headquartered in Mexico (MX) and operates extensively across Latin America and the United States. Founded in 2000, the company has achieved significant milestones, including rapid expansion and a diverse product portfolio that encompasses over-the-counter medications, skincare, and dietary supplements. Renowned for its innovative approach, Genomma Lab offers unique formulations that cater to various health and wellness needs, setting it apart in a competitive market. With a strong commitment to quality and research, the company has established a solid market position, recognised for its effective solutions and consumer trust. Genomma Lab Internacional continues to thrive, driven by its dedication to enhancing the well-being of its customers.
DitchCarbon Score
How does Genomma Lab Internacional's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Genomma Lab Internacional's score of 34 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Genomma Lab Internacional's reported carbon emissions
In 2023, Genomma Lab Internacional reported total carbon emissions of approximately 51,000,000 kg CO2e, comprising 3,100,840 kg CO2e from Scope 1, 4,740,490 kg CO2e from Scope 2, and about 44,075,120 kg CO2e from Scope 3 emissions. This marks a slight increase in emissions compared to 2022, where total emissions were around 43,466,980 kg CO2e from Scope 3, 4,041,110 kg CO2e from Scope 2, and 2,737,470 kg CO2e from Scope 1. The company has not set specific reduction targets under the Science Based Targets initiative (SBTi) or disclosed any climate pledges. However, it is committed to monitoring and reporting its emissions transparently, as evidenced by its annual reports. The emissions data is not cascaded from any parent organization, indicating that Genomma Lab Internacional independently tracks its carbon footprint. Overall, Genomma Lab Internacional's emissions profile highlights the significant impact of Scope 3 emissions, which account for the majority of its carbon footprint, reflecting industry trends where upstream and downstream activities contribute substantially to total emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 602,630 | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 1,471,900 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 172,410 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Genomma Lab Internacional is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
